Topas Therapeutics Raises EUR 14 Million to Treat Immunological Disorders
March 22, 2016
Hamburg, Germany, 22 March 2016 – Topas Therapeutics GmbH (“Topas”), a Hamburg/Germany based company, today announced the closing of its Series A financing round. This